Research progress on the relationship between intestinal flora and atrial fibrillation
-
摘要: 肠道微生物群是一个复杂的动态生态系统，包含数万亿微生物，它们产生影响宿主健康和疾病发展的生物活性代谢物。近年来，大量研究证明，肠道菌群及其衍生代谢物影响着心血管疾病的发生发展，其中就包括心律失常，而心房颤动作为最常见的心律失常，不乏有关于其的相关研究。本综述就心房颤动与肠道菌群及其代谢物的相关性展开叙述。Abstract: The gut microbiota is a complex and dynamic ecosystem containing trillions of microorganisms that produce bioactive metabolites that affect host health and disease development. In recent years, a large number of studies have proved that the intestinal microbiota and its derived metabolites affect the occurrence and development of cardiovascular diseases, including arrhythmia, and atrial fibrillation. This review describes the association of atrial fibrillation with the gut microbiota and its metabolites.
-
-
[1] Gawałko M, Agbaedeng TA, Saljic A, et al. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications[J]. Cardiovasc Res, 2022, 118(11): 2415-2427. doi: 10.1093/cvr/cvab292
[2] Zuo K, Li J, Li K, et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation[J]. Gigascience, 2019, 8(6): 110.
[3] Zhang Y, Zhang S, Li B, et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome[J]. Cardiovasc Res, 2022, 118(3): 785-797. doi: 10.1093/cvr/cvab114
[4] Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. [J]. Cell, 2012, 148(6): 1258-1270. doi: 10.1016/j.cell.2012.01.035
[5] Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis[J]. Cell Mol Life Sci, 2017, 74(16): 2959-2977. doi: 10.1007/s00018-017-2509-x
[6] Zhou W, Cheng Y, Zhu P, et al. Implication of gut microbiota in cardiovascular diseases[J]. Oxid Med Cell Longev, 2020, 2020: 5394096.
[7] Tabata T, Yamashita T, Hosomi K, et al. Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs[J]. Heart Vessels, 2021, 36(1): 105-114. doi: 10.1007/s00380-020-01669-y
[8] Zuo K, Yin X, Li K, et al. Different types of atrial fibrillation share patterns of gut microbiota dysbiosis[J]. mSphere, 2020, 5(2): 110.
[9] 晏家升, 吕冰洁, 程翔. 肠道菌群调节免疫系统影响心血管疾病的研究进展[J]. 临床心血管病杂志, 2022, 38(8): 614-618. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.08.004
[10] Li J, Zuo K, Zhang J, et al. Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation[J]. J Cell Mol Med, 2020, 24(22): 13356-13369. doi: 10.1111/jcmm.15959
[11] Blöbaum L, Witkowski M, Wegner M, et al. Intestinal barrier dysfunction and microbial translocation in patients with first-diagnosed atrial fibrillation[J]. Biomedicines, 2023, 11(1): 110. doi: 10.3390/biomedicines11010110
[12] Yao C, Veleva T, Scott L Jr, et al. Enhanced Cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation[J]. Circulation, 2018, 138(20): 2227-2242. doi: 10.1161/CIRCULATIONAHA.118.035202
[13] Wang M, Xiong H, Lu L, et al. Serum lipopolysaccharide is associated with the recurrence of atrial fibrillation after radiofrequency ablation by increasing systemic inflammation and atrial fibrosis[J]. Oxid Med Cell Longev, 2022, 2022: 2405972.
[14] Zhang Y, Zhang S, Li B, et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome[J]. Cardiovasc Res, 2022, 118(3): 785-797. doi: 10.1093/cvr/cvab114
[15] Linz D, Gawałko M, Sanders P, et al. Does gut microbiota affect atrial rhythm? Causalities and speculations[J]. Eur Heart J, 2021, 42(35): 3521-3525. doi: 10.1093/eurheartj/ehab467
[16] Xu J, Yang Y. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases[J]. Gut Microbes, 2021, 13(1): 1936379. doi: 10.1080/19490976.2021.1936379
[17] Bartolomaeus H, Balogh A, Yakoub M, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage[J]. Circulation, 2019, 139(11): 1407-1421. doi: 10.1161/CIRCULATIONAHA.118.036652
[18] Gao X, Lin SH, Ren F, et al. Acetate functions asan epigenetic metabolite to promote lipid synthesis under hypoxia[J]. Nat Commun, 2016, 7: 11960. doi: 10.1038/ncomms11960
[19] Svingen G, Zuo H, Ueland PM, et al. Increased plasmatrimethylamine-N-oxide is associated with incident atrialfibrillation[J]. Inter J Cardiol, 2018, 267: 100-106. doi: 10.1016/j.ijcard.2018.04.128
[20] Huang R, Yan L, Lei YH. The Gut Microboal-Derived Metabolite Trimethyamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies[J]. Clinical Interventions in Aging, 2021, 16: 1975-1986. doi: 10.2147/CIA.S339590
[21] Tabata T, Yamashita T, Hosomi K, et al. Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs[J]. Heart Vessels, 2021, 36(1): 105-114. doi: 10.1007/s00380-020-01669-y
[22] Meng G, Zhou X, Wang M, et al. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways[J]. E Bio Medicine, 2019, 44: 656-664.
[23] Yu L, Meng G, Huang B, et al. A potential relationship between gutmicrobes and atrial fibrillation: trimethylamine N-oxide, a gut microbe-derivedmetabolite, facilitates the progression of atrial fibrillation[J]. Int J Cardiol, 2018, 255: 92-98. doi: 10.1016/j.ijcard.2017.11.071
[24] Sohns C, Marrouche NF. Atrial fibrillation and cardiac fibrosis[J]. Eur Heart J, 2020, 41: 1123-1131. doi: 10.1093/eurheartj/ehz786
[25] Li Z, Wu Z, Yan J, et al. Gut microbe-derived metabolite trimethy lamine N-oxide induces cardiac hypertrophy and fibrosis[J]. Lab Invest, 2019, 99(3): 346-357. doi: 10.1038/s41374-018-0091-y
[26] Zhen J, Zhou Z, He M, et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases[J]. Front Endocrinol(Lausanne), 2023, 14: 1085041. doi: 10.3389/fendo.2023.1085041
[27] Wang G, Kong B, Shuai W, et al. 3, 3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice[J]. J Nutr Biochem, 2020, 78: 108341. doi: 10.1016/j.jnutbio.2020.108341
[28] Huynh K. Novel gut microbiota-derived metabolite promotes platelet thrombosis via adrenergic receptor signalling[J]. Nat Rev Cardiol, 2020, 17(5): 265. doi: 10.1038/s41569-020-0367-y
[29] Gong D, Zhang L, Zhang Y, et al. Gut microbial metabolite trimethylamine N-oxide is relatedto thrombus formation in atrial fibrillation patients[J]. Am J Med Sci, 2019, 358(6): 422-428. doi: 10.1016/j.amjms.2019.09.002
[30] Yang WT, Yang R, Zhao Q, et al. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation[J]. Ann Palliat Med, 2021, 10(11): 11512-11523. doi: 10.21037/apm-21-2763
[31] Fang C, Zuo K, Zhang W, et al. Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrilliation Patients[J]. Int J Pract, 2022, 10: 7942605.
[32] Zuo K, Li J, Wang P, et al. Duration of persistent atrial fibrillation is associated with alterations in human gut microbiota and metabolic phenotypes[J]. mSystems, 2019, 4(6): e00422-00419.
[33] Zuo K, Fang C, Liu Z. Commensal microbederived SCFA alleviates atrial fibrillation via GPR43/NLRP3signaling[J]. Int J Bio Sci, 2022, 18(10): 4219-4232. doi: 10.7150/ijbs.70644
[34] Lu D, Zou X, Zhang H. The relationship between atrial fibrillation and intestinal flora with its metabolites[J]. Front Cardiovasc Med, 2022, 9: 948755. doi: 10.3389/fcvm.2022.948755
[35] Chen WT, Chen YC, Hsieh MH, et al. The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis[J]. J Cardiovasc Electrophysiol, 2015, 26: 203-210. doi: 10.1111/jce.12554
[36] Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341): 57-63. doi: 10.1038/nature09922
[37] Fang C, Zuo K, Jiao K, et al. PAGln, an atrial fibrillation-linked gut microbial metabolite, acts as a promoter of atrial myocyte injury[J]. Biomolecules, 2022, 12(8): 110.
[38] Huang X, Gao H, Jiang X, et al. Urolithin B, a gut microbiota metabolite, reduced susceptibility to myocardial arrhythmic predisposition after hypoxia[J]. Dis Markers, 2022, 2022: 6517266.
[39] Zheng D, Liu Z, Zhou Y, et al. Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway[J]. Pharmacol Res, 2020, 153: 104655. doi: 10.1016/j.phrs.2020.104655
[40] Gao H, Huang X, Tong Y, et al. Urolithin B improves cardiac function and reduces susceptibility to ventricular arrhythmias in rats after myocardial infarction[J]. Eur J Pharmacol, 2020, 871: 172936. doi: 10.1016/j.ejphar.2020.172936
[41] Oniszczuk A, Oniszczuk T, Gancarz M, et al. Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases[J]. Molecules, 2021, 26: 1172. doi: 10.3390/molecules26041172
[42] Chen Q, Liu M, Zhang P, et al. Fucoidan and galactooligosaccharides ameliorate high-fat diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism[J]. Nutrition, 2019, 65: 50-59.
[43] Long MT, Darae K, Arnold LM, et al. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature[J]. Therapeutic Advances in Gastroenterology, 2019, 12: 1-19.
[44] Sun L, Pang Y, Wang X, et al. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters[J]. Acta Pharm Sin B, 2019, 9(4): 702-710.
[45] Le Roy T, Lécuyer E, Chassaing B, et al. The intestinal microbiota regulates host cholesterol homeostasis[J]. BMC Biol, 2019, 17(1): 94.
-
计量
- 文章访问数: 821
- PDF下载数: 105
- 施引文献: 0
下载: